CareDx, Inc
CDNA
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cā¦ read more
Healthcare
Diagnostics & Research
11 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$19.45
Price+1.36%
$0.26
1Y
Price
Market Cap
$1b
Small
Price/Earnings 3y Avg5y Avg
15.2x
Premium
Premium
Financials Overview
Key metrics over the past few years+6.8%
EBITDA Margin+1.7%
Net Profit Margin+36.0%
Free Cash Flow MarginRevenue
$357.998m
+7.2%
1y CAGR+4.5%
3y CAGR+5.5%
5y CAGREarnings
$60.764m
+15.6%
1y CAGR-1.7%
3y CAGR-38.7%
5y CAGREPS
$1.19
+28.0%
1y CAGR+2.8%
3y CAGR-33.9%
5y CAGRBook Value
$311.140m
$432.307m
Assets$121.167m
Liabilities$27.644m
DebtDebt to Assets
6.4%
-1.6x
Debt to EBITDAFree Cash Flow
$37.094m
+17.5%
1y CAGR+92.0%
3y CAGR+62.7%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company